ACRS - Financial Reports List - Aclaris Therapeutics, Inc. - IntrinsicAlpha

Aclaris Therapeutics, Inc. ACRS

Healthcare - Medical - Diagnostics & Research - NASDAQ - US

$ 1.29

-4.44 %

$ 140 M

Market Cap

-0.81

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	-39.32%	10.96%	-32.67%
Quarterly Report	Q4	8-K	2024-12-31	-47.58%	-6375.65%	-2362.94%
Annual Report	FY	10-K	2024-12-31	-40.09%	-49.26%	-45.79%
Quarterly Report	Q3	8-K	2024-09-30	-53.18%	74.07%	66.84%
Quarterly Report	Q2	8-K	2024-06-30	47.99%	62.85%	60.54%
Quarterly Report	Q1	8-K	2024-03-31	-5.14%	35.83%	55.63%
Quarterly Report	Q4	8-K	2023-12-31	126.62%	95.52%	81.59%
Annual Report	FY	10-K	2023-12-31	5.03%	0.20%	-14.33%
Quarterly Report	Q3	8-K	2023-09-30	-51.19%	-37.83%	-69.10%
Quarterly Report	Q2	8-K	2023-06-30	22.32%	-77.38%	-30.42%

1